Brokerages predict that Valeritas Holdings Inc (NASDAQ:VLRX) will announce earnings of ($0.56) per share for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for Valeritas’ earnings. Valeritas posted earnings per share of ($1.62) in the same quarter last year, which suggests a positive year over year growth rate of 65.4%. The business is expected to announce its next quarterly earnings results before the market opens on Friday, November 9th.
On average, analysts expect that Valeritas will report full-year earnings of ($2.76) per share for the current financial year. For the next fiscal year, analysts anticipate that the company will post earnings of ($2.03) per share. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side analysts that that provide coverage for Valeritas.
Valeritas (NASDAQ:VLRX) last posted its quarterly earnings results on Tuesday, August 7th. The company reported ($0.62) EPS for the quarter, topping analysts’ consensus estimates of ($0.73) by $0.11. The business had revenue of $6.50 million during the quarter, compared to analysts’ expectations of $6.30 million. Valeritas had a negative net margin of 205.12% and a negative return on equity of 1,768.69%.
Separately, Oppenheimer set a $4.00 price objective on shares of Valeritas and gave the company a “buy” rating in a research note on Tuesday, August 7th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $3.67.
Several institutional investors have recently added to or reduced their stakes in VLRX. Bainco International Investors bought a new position in shares of Valeritas in the second quarter valued at $228,000. C WorldWide Group Holding A S lifted its stake in shares of Valeritas by 28.0% in the second quarter. C WorldWide Group Holding A S now owns 316,194 shares of the company’s stock valued at $424,000 after buying an additional 69,216 shares in the last quarter. Finally, Essex Investment Management Co. LLC bought a new position in shares of Valeritas in the second quarter valued at $448,000. 7.38% of the stock is currently owned by hedge funds and other institutional investors.
NASDAQ:VLRX traded down $0.03 during trading hours on Wednesday, reaching $1.15. The company had a trading volume of 336,300 shares, compared to its average volume of 586,983. The company has a current ratio of 4.03, a quick ratio of 3.42 and a debt-to-equity ratio of 13.66. The stock has a market capitalization of $28.34 million, a price-to-earnings ratio of -0.14 and a beta of 2.58. Valeritas has a twelve month low of $0.78 and a twelve month high of $6.79.
Valeritas Company Profile
Valeritas Holdings, Inc, a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with Type 2 diabetes in the United States and China. It offers V-Go, a wearable insulin delivery device for basal-bolus therapy. The company also develops h-Patch, a controlled delivery technology platform; Mini-Ject technology for needle-free injection systems; and Micro-Trans technology for microneedle design, fabrication, and drug delivery.
Featured Story: What is Considered a Good Return on Equity (ROE)?
Get a free copy of the Zacks research report on Valeritas (VLRX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Valeritas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeritas and related companies with MarketBeat.com's FREE daily email newsletter.